BE

MDxHealth Provides Q3-2021 Business Update

Retrieved on: 
Thursday, October 21, 2021
Bachelor of Arts, Diagnosis, University, Prognosis, Cancer, University of North Carolina School of the Arts, LabCorp, Genetics, Patient, Quest Diagnostics, Methylation, Physician, Don, Social media, Chapel Hill, Company, CEO, Growth, Nasdaq, Prostate cancer, Management, Medical imaging

From April 2010 to March 2016, Mr. Hardison was the President and Chief Executive Officer of Good Start Genetics, a molecular genetic testing and information company.

Key Points: 
  • From April 2010 to March 2016, Mr. Hardison was the President and Chief Executive Officer of Good Start Genetics, a molecular genetic testing and information company.
  • Michael K. McGarrity, CEO of MDxHealth commented: We are very excited to welcome Don Hardison to our board of directors.
  • Dons breadth of experience and reach into the U.S. and global diagnostic industry will serve MDxHealth well as we go forward.
  • MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer.

Hyloris Announces Approval of Maxigesic® IV in the UK and Ireland

Retrieved on: 
Tuesday, October 19, 2021
Epidemiology, CAGR, Euronext, LinkedIn, Surgeon, Issuer, IV, Analgesic, Patient, Industry, Atrial fibrillation, Pain, Safety, Company, Pharmaceutical industry

Maxigesic IV has now obtained regulatory approvals in the UK and Ireland, thereby increasing the number of countries in which Hyloris partner AFT Pharmaceuticals obtained regulatory approval for Maxigesic IV to 27 countries, from 21 countries at the end of March 2021.

Key Points: 
  • Maxigesic IV has now obtained regulatory approvals in the UK and Ireland, thereby increasing the number of countries in which Hyloris partner AFT Pharmaceuticals obtained regulatory approval for Maxigesic IV to 27 countries, from 21 countries at the end of March 2021.
  • Kensington Pharmaceuticals Ltd., the distributor for the UK, and Jed Pharma Ltd, the distributor in Ireland, are now gearing up to commence sales in the first quarter of 2022.
  • Maxigesic IV has been developed under the collaboration agreement signed in 2012 between Hyloris and AFT Pharmaceuticals.
  • Two products are currently in initial phases of commercialisation with partners: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a non-opioid post-operative pain treatment.

Award-Winning Author Laura J. Wellington Wins the "Firebird Book Award"

Retrieved on: 
Sunday, October 17, 2021
Love, BE, Survival, Tragedy, Magic, Be Careful What You Wish For, Reader, Gold, Film, Book

Deeply moving, unexpectedly provocative, and wildly engaging, many readers finish reading the book in one sitting -- additionally coaxed by the fascinating way Wellington weaves the paranormal element into the story. More than simply an incredible love story, each page moves you through a life filled with love, tragedy, survival, and rebirth -- an epic tale reminding readers of the power of the human spirit. It is a reminder we all need today in our own individual worlds as well as in our entertainment.

Key Points: 
  • This is Laura J. Wellington's second significant recognition for the book.
  • Critics have hailed the book as a "magnum opus" while readers denote how closely they see themselves in it.
  • Readers are already asking when the sequel will be written as the book hints that there will be one.
  • As Wellington is currently working on several new projects, she hasn't yet decided when that will happen.

Selligent Releases Selligent Data Studio PRO, a Dashboard and Reporting Solution for Selligent Marketing Cloud

Retrieved on: 
Thursday, October 14, 2021
Cloud, Travel, Google Data Studio, LinkedIn, Marketing, CM, Blog, SDS, LLC, Data collection, GLOBE, E-commerce, Publishing, Shoe, Twitter, Partnership, Cassette tape, Sales

BRUSSELS, Belgium and NASHVILLE, Tenn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent) , the intelligent omnichannel marketing cloud platform and CM Group brand, today announced the launch of Selligent Data Studio PRO (SDS PRO).

Key Points: 
  • BRUSSELS, Belgium and NASHVILLE, Tenn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent) , the intelligent omnichannel marketing cloud platform and CM Group brand, today announced the launch of Selligent Data Studio PRO (SDS PRO).
  • SDS PRO is a flexible dashboarding and reporting solution for Selligent Marketing Cloud.
  • It allows marketing teams to build and share customized dashboards using data available within Selligent and combine it with data stored in other data sources.
  • Selligent Data Studio is the most advanced marketing reporting and dashboarding solution I have seen in my 20 years of experience.

Selligent Releases Selligent Data Studio PRO, a Dashboard and Reporting Solution for Selligent Marketing Cloud

Retrieved on: 
Thursday, October 14, 2021
Cloud, Travel, Google Data Studio, LinkedIn, Marketing, CM, Blog, SDS, LLC, Data collection, GLOBE, E-commerce, Publishing, Shoe, Twitter, Partnership, Cassette tape, Sales

BRUSSELS, Belgium and NASHVILLE, Tenn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent), the intelligent omnichannel marketing cloud platform and CM Group brand, today announced the launch of Selligent Data Studio PRO (SDS PRO). SDS PRO is a flexible dashboarding and reporting solution for Selligent Marketing Cloud. It allows marketing teams to build and share customized dashboards using data available within Selligent and combine it with data stored in other data sources. By consolidating data and creating detailed views of audiences and their interactions across channels, SDS PRO solves for several key marketer pain points.

Key Points: 
  • BRUSSELS, Belgium and NASHVILLE, Tenn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Selligent Marketing Cloud (Selligent) , the intelligent omnichannel marketing cloud platform and CM Group brand, today announced the launch of Selligent Data Studio PRO (SDS PRO).
  • SDS PRO is a flexible dashboarding and reporting solution for Selligent Marketing Cloud.
  • It allows marketing teams to build and share customized dashboards using data available within Selligent and combine it with data stored in other data sources.
  • Selligent Data Studio is the most advanced marketing reporting and dashboarding solution I have seen in my 20 years of experience.

MDxHealth files Registration Statement for Proposed Initial Public Offering in the United States

Retrieved on: 
Wednesday, October 13, 2021
The Company, ADSS, SEC, SEC filing, Broad Street, Minnesota, Form, Securities and Exchange Commission (Philippines), Company, Nasdaq, Prospectus, Sale, Attention, American depositary receipt, Nicollet Mall, CA, KBC, U.S. Securities and Exchange Commission, Security (finance)

The number of ADSs to be offered and the timing and price range for the proposed offering have not yet been determined.

Key Points: 
  • The number of ADSs to be offered and the timing and price range for the proposed offering have not yet been determined.
  • The public offering is expected to take place after the SEC completes its review process, subject to market and other conditions, including the effectiveness of the abovementioned registration statement.
  • The proposed offering of ordinary shares in the United States will be made only by means of a prospectus.
  • NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx and SelectMDx are trademarks or registered trademarks of MDxHealth SA ("MDxHealth").

Hyloris Acquires Breakthrough, Patented Technology to Develop and Market Aspirin IV in the U.S. in Acute Coronary Syndrome

Retrieved on: 
Wednesday, October 13, 2021
Cardiovascular disease, Company, NDA, Intellectual property, Patient, Center, CHD, IV, Coronary artery disease, Atrial fibrillation, American Heart Association, Heart, Unstable angina, LinkedIn, Mortality, Safety, Chest pain, Industry, Population, Roemheld syndrome, FDA, Cardiology, Cardiac arrest, CM, Issuer, Infarction, Artery, Acute coronary syndrome, Euronext, Myocardial infarction, Partnership, ACS, Moyamoya disease, Pharmaceutical industry

Stijn Van Rompay, Chief Executive Officer of Hyloris, added: Developing an IV formulation of acetylsalicylic acid, the active ingredient of Aspirin, is a challenge due to its inherent chemical instability and poor solubility.

Key Points: 
  • Stijn Van Rompay, Chief Executive Officer of Hyloris, added: Developing an IV formulation of acetylsalicylic acid, the active ingredient of Aspirin, is a challenge due to its inherent chemical instability and poor solubility.
  • We are very pleased to join forces with the team at Rhoshan and implement their breakthrough, proven IV formulation technology to accelerate the development of HY-073, thereby shortening overall timelines.
  • About coronary heart disease (CHD), acute coronary syndrome (ACS) and Aspirin IV U.S.
    CHD occurs when the hearts blood supply is blocked due to the build-up of fatty substances in the arteries around the heart.
  • Rhoshan Pharmaceuticals, Inc is a specialty biopharmaceutical company focused on bringing the first injectable aspirin to US market.

Oxurion NV Announces First Patient Dosed in its Phase 2 Study Evaluating THR-687 for the treatment of Diabetic Macular Edema (DME)

Retrieved on: 
Wednesday, October 13, 2021
Injection, DME, INTEGRAL, Trial of the century, AMD, Standard of care, CFA, Safety, Human, Diabetic retinopathy, Clinical research, Intravitreal injection, BE, RVO, Month, Eye disease, Euronext, Patient, M.A, CST, Pharmaceutical industry, Vaccine

The INTEGRAL study is a Phase 2, randomized, multicenter trial and is the first study in which multiple intravitreal injections of THR-687 will be administered in humans.

Key Points: 
  • The INTEGRAL study is a Phase 2, randomized, multicenter trial and is the first study in which multiple intravitreal injections of THR-687 will be administered in humans.
  • Part A is being conducted in treatment nave subjects to select the optimal THR-687 dose level to be assessed in Part B.
  • Part B will be conducted in both treatment nave and treatment experienced subjects to evaluate the efficacy and safety of THR-687 compared to aflibercept.
  • Similarly, a peak mean CST decrease of 106 m was observed at Day 14 with the highest dose of THR-687.

Greene Concepts Announces Contest for Chance to Win VIP Fan Experience For Upcoming NASCAR Camping World Truck Series Race at Phoenix Raceway

Retrieved on: 
Tuesday, October 12, 2021
Water, Twitter, NASCAR Camping World Truck Series, OTC Markets Group, Blue Ridge Mountains, Comment, Phoenix Raceway, Social media, GLOBE, Safe harbor, VIP, Securities Exchange Act of 1934, U.S. Securities and Exchange Commission, NASCAR, BE, Securities Act of 1933, Security (finance), CEO, Awareness, Camping, Fed, Amazon, Disclosure, Public relations

Marion, North Carolina, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Greene Concepts, Inc. (OTC Pink: INKW) is pleased to announce an opportunity for one lucky individual to win a VIP experience at NASCAR Camping World Truck Series Race at the Phoenix Raceway.

Key Points: 
  • Marion, North Carolina, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Greene Concepts, Inc. (OTC Pink: INKW) is pleased to announce an opportunity for one lucky individual to win a VIP experience at NASCAR Camping World Truck Series Race at the Phoenix Raceway.
  • The contest includes the chance to win two VIP tickets, accommodations, and a meet and greet with Dawson Cram at the NASCAR Camping World Truck Series Lucas Oil 150 Race held November 5 at 8:30 pm ET at the Phoenix Raceway (see NASCAR Camping World Truck Series Schedule page ) with broadcasting beginning at 8:00 pm ET.
  • The sweepstakes is free to enter, simply Like Greene Concepts on Facebook , Twitter, or Instagram , then visit bewaterbeyou.com/sweepstakes to fill out the entry form.
  • Lenny Greene, CEO of Greene Concepts, states, I am extremely happy to offer this chance to the public to spread awareness of Greene Concepts and Be WaterTM.

Greene Concepts Extends the Sponsorship of Dawson Cram and Cram Racing Enterprises to Include Races at Martinsville Speedway and Phoenix Raceway

Retrieved on: 
Tuesday, October 12, 2021
Water, Silverado, 2018 NASCAR Camping World Truck Series, OTC Markets Group, Be Water, Lucas Oil 150, Blue Ridge Mountains, Chevrolet, Phoenix Raceway, DK, GLOBE, Lucas, Safe harbor, Camping World, Securities Exchange Act of 1934, U.S. Securities and Exchange Commission, NASCAR, BE, Securities Act of 1933, Security (finance), Martinsville Speedway, Greene, CEO, Awareness, Partnership, Camping, NASCAR Camping World Truck Series, Cram Racing Enterprises, Fed, Disclosure, Bottled water

I am very excited to have Be Water back on board our #41 Silverado to close out the 2021 season, said DK Cram.

Key Points: 
  • I am very excited to have Be Water back on board our #41 Silverado to close out the 2021 season, said DK Cram.
  • Both Martinsville and Phoenix hold career best finishes for myself, so Im excited to have the opportunity to have some good runs for the folks at Be Water!
  • Cram Racing Enterprises isan American professional stock car racing teamthat competes in the NASCAR Camping World Truck Series, fielding the #41 Chevrolet Silverado primarily piloted by NASCAR driver and team co-owner, Dawson Cram.
  • Greene Concepts continues to develop and market premium beverage brands designed to enhance the daily lives of consumers.